Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Suven Pharmaceuticals Ltd. ( (IN:SUVENPHAR) ) is now available.
Suven Pharmaceuticals Ltd has announced a revised schedule for their conference call to discuss the unaudited financial results for the third quarter and nine months of the fiscal year 2025. The call, which will include key members of the management team, is set to take place on February 12, 2025. This conference call is an important event for investors and stakeholders, as it will provide insights into the company’s financial performance and strategic direction.
More about Suven Pharmaceuticals Ltd.
Suven Pharmaceuticals Ltd is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company is headquartered in Mumbai and Hyderabad, India, and is known for its commitment to innovation and quality in the pharmaceutical sector.
YTD Price Performance: 2.78%
Average Trading Volume: 9,305
Current Market Cap: 294.1B INR
Learn more about SUVENPHAR stock on TipRanks’ Stock Analysis page.